Initial U.S. production run moves the Company's second transdermal peptide product from successful testing toward direct-to-consumer and wholesale availabilityHighlightsOrder placed for 20,000 units of
crime
The Precision Peptide Company Inc.: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
📡 via
finanznachrichten.de
🗺 View Live on Interactive Map
Community Confidence: 40%